For best results when printing this announcement, please click on link below:
http://newsfile.refinitiv.com/getnewsfile/v1/story?guid=urn:newsml:reuters.com:20240416:nRSP7065Ka&default-theme=true
RNS Number : 7065K Judges Scientific PLC 16 April 2024
Judges Scientific plc
Director/PDMR Shareholding
Judges Scientific plc (AIM: JDG), a group focused on acquiring and
developing companies in the scientific instrument sector announces that Brad
Ormsby, Chief Financial Officer, on 15 April 2024 exercised options over
21,000 ordinary shares of 5p each in the Company ("Ordinary Shares"), and
subsequently sold 20,424 Ordinary Shares at a price of 11,200 pence per
Ordinary Share.
This results in an increased beneficial holding by 576 to 4,512 Ordinary
Shares representing approximately 0.07% of the total issued share capital and
voting rights in the Company.
Following this exercise of options, the Company's total issued share capital
has increased to 6,639,974 Ordinary Shares. There are no Ordinary Shares held
in treasury. Each Ordinary Share carries voting rights on the basis of one
vote per Ordinary Share. Therefore, the total number of voting rights in
Judges Scientific is 6,639,974 Ordinary Shares. The above figure may be used
by shareholders as the denominator for calculations to determine if they have
a notifiable interest in Judges Scientific under the Disclosure and
Transparency Rules, or if such interest has changed.
1 Details of the person discharging managerial responsibilities / person closely
associated
a) Name Bradley Ormsby
2 Reason for the notification
a) Position/status Chief Financial Officer
b) Initial notification /Amendment Initial notification
3 Details of the issuer, emission allowance market participant, auction
platform, auctioneer or auction monitor
a) Name Judges Scientific plc
b) LEI 2138004EXWWPTW1JOL31
4 Details of the transaction(s): section to be repeated for (i) each type of
instrument; (ii) each type of transaction; (iii) each date; and (iv) each
place where transactions have been conducted
a) Description of the financial instrument, type of instrument Ordinary shares in Judges Scientific plc
Identification code
GB0032398678
b) Nature of the transaction Exercise of options
c) Price(s) and volume(s)
Price(s) Volume(s)
6,580.0p 20,000
5,200.0p 1,000
d) Aggregated information N/A (single transaction)
- Aggregated volume
- Price
e) Date of the transaction 15/04/2024
f) Place of the transaction Outside a trading venue
d)
Aggregated information
- Aggregated volume
- Price
N/A (single transaction)
e)
Date of the transaction
15/04/2024
f)
Place of the transaction
Outside a trading venue
1 Details of the person discharging managerial responsibilities / person closely
associated
a) Name Bradley Ormsby
2 Reason for the notification
a) Position/status Chief Financial Officer
b) Initial notification /Amendment Initial notification
3 Details of the issuer, emission allowance market participant, auction
platform, auctioneer or auction monitor
a) Name Judges Scientific plc
b) LEI 2138004EXWWPTW1JOL31
4 Details of the transaction(s): section to be repeated for (i) each type of
instrument; (ii) each type of transaction; (iii) each date; and (iv) each
place where transactions have been conducted
a) Description of the financial instrument, type of instrument Ordinary shares in Judges Scientific plc
Identification code
GB0032398678
b) Nature of the transaction Sale of shares
c) Price(s) and volume(s)
Price(s) Volume(s)
11,200.0p 20,424
d) Aggregated information N/A (single transaction)
- Aggregated volume
- Price
e) Date of the transaction 15/04/2024
f) Place of the transaction London Stock Exchange, AIM Market (XLON)
d)
Aggregated information
- Aggregated volume
- Price
N/A (single transaction)
e)
Date of the transaction
15/04/2024
f)
Place of the transaction
London Stock Exchange, AIM Market (XLON)
- Ends -
For further information please contact:
Judges Scientific plc Shore Capital (Nominated Adviser & Joint Broker)
David Cicurel, CEO Stephane Auton
Brad Ormsby, CFO Harry Davies-Ball
Tel: +44 (0) 20 3829 6970 Tel: +44 (0) 20 7408 4090
Liberum (Joint Broker) Investec Bank plc (Joint Broker)
Edward Mansfield Virginia Bull
Nikhil Varghese Carlton Nelson
Tel : +44 (0) 20 3100 2222 Tel: +44 (0) 207 597 4000
Alma Strategic Communications (Financial Public Relations)
Sam Modlin
Rebecca Sanders-Hewett
Joe Pederzolli
Tel: +44 (0) 20 3405 0205
judges@almastrategic.com
Notes to editors:
Judges Scientific plc (AIM: JDG), is a group focused on acquiring and
developing companies in the scientific instrument sector. The Group now
consists of 23 businesses acquired since 2005.
The acquired companies are primarily UK-based with products sold worldwide to
a diverse range of markets including: higher education institutions,
scientific research facilities, manufacturers and regulatory authorities.
The UK is a recognised centre of excellence for scientific instruments.
The Group has received five Queen's Awards for innovation and export.
The Group's companies predominantly operate in global niche markets, with long
term growth fundamentals and resilient margins.
Judges Scientific maintains a policy of selectively acquiring businesses that
generate sustainable profits and cash. Shareholder returns are created
through the reduction of debt, organic growth and dividends.
For further information, please visit www.judges.uk.com
(https://url.avanan.click/v2/___http:/www.judges.uk.com/___.YXAxZTpzaG9yZWNhcDphOm86M2M4NzY3NGU5MjMxNzExOWZjYjg5ODlkYjkxNmZmZDI6NjoxMTMwOjk3ZWNjN2I3YmJmODJiYTYyYzE0NjI5NzI5NzQzMTEzY2NkOWJlMDYxNWM5OTcyYTU2YmJhNGU0NDYyNGRkNzI6cDpU)
This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact
rns@lseg.com (mailto:rns@lseg.com)
or visit
www.rns.com (http://www.rns.com/)
.
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our
Privacy Policy (https://www.lseg.com/privacy-and-cookie-policy)
. END DSHBCGDSGGBDGSU